Advanced glycation end products and mortality in hemodialysis patients
- 1 July 2002
- journal article
- Published by Elsevier in Kidney International
- Vol. 62 (1) , 301-310
- https://doi.org/10.1046/j.1523-1755.2002.00423.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Advanced Glycation End Products in End-Stage Renal Disease and Their RemovalNephron, 2001
- Advanced glycation end products: A nephrologist's perspectiveAmerican Journal of Kidney Diseases, 2000
- Alterations in nonenzymatic biochemistry in uremia: Origin and significance of “carbonyl stress” in long-term uremic complicationsKidney International, 1999
- AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE conceptPublished by Oxford University Press (OUP) ,1998
- Renal catabolism of advanced glycation end products: The fate of pentosidineKidney International, 1998
- Pharmacology of methylglyoxal: formation, modification of proteins and nucleic acids, and enzymatic detoxification-A role in pathogenesis and antiproliferative chemotherapyGeneral Pharmacology: The Vascular System, 1996
- The Advanced Glycation End Product, N∊-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation ReactionsJournal of Biological Chemistry, 1996
- Renal fate of circulating advanced glycated end products (AGE): evidence for reabsorption and catabolism of AGE-peptides by renal proximal tubular cellsDiabetologia, 1996
- ADVANCED PROTEIN GLYCOSYLATION IN DIABETES AND AGINGAnnual Review of Medicine, 1995
- Advanced Glycosylation End Products in Patients with Diabetic NephropathyNew England Journal of Medicine, 1991